Aggressive vs nonaggressive therapy for metastatic NSCLC.
Thatcher, Nick Niven, Robert McL Anderson, Heather
Thatcher, Nick
Niven, Robert McL
Anderson, Heather
Citations
Altmetric:
Abstract
Clinicians tend to underestimate potential modest benefits of chemotherapy. They are often reluctant to refer patients for chemotherapy, perhaps because they expect the side effects to outweigh any perceived benefits. However, patients are much more ready to accept chemotherapy, even when the likely benefits are small. Quality of life, change in performance status, and relief of tumor-related symptoms are important additional parameters of treatment assessment. Taking account of these other factors will help clinicians balance quality and quantity of life in patients with metastatic non-small cell lung cancer.
Description
Date
1996-05
Publisher
Collections
Keywords
Lung Cancer
Type
Article
Citation
Aggressive vs nonaggressive therapy for metastatic NSCLC. 1996, 109 (5 Suppl):87S-92S Chest